Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001263244-26-000002

Options or other derivatives

  • Chief Financial Officer acquired 123,019 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
CURHAN GREGORY S Chief Financial Officer 2026-05-21 Grant or award · Stock Option (right to buy) +123,019 123,019 D
Loading xslF345X06/wk-form4_1779838527.xml…